Trevena ( (TRVN) ) has shared an update.
On October 5, 2024, a company implemented cost-cutting measures leading to the termination of its President and CEO, Executive VP/COO/CFO, and Senior VP/Chief Medical Officer. Despite the terminations, these officers will continue to serve in acting roles. Separation Agreements were set to outline severance entitlements, and consulting agreements were established for the departing executives to continue advising on corporate strategy and other business matters at compensation levels aligned with their former salaries.
See more data about TRVN stock on TipRanks’ Stock Analysis page.
